NEW YORK, Feb. 23, 2025 (GLOBE NEWSWIRE) -- BioAstra, a pioneering force in space medicine and biotechnology, is set to revolutionize human health with the launch of Twin Astra—a first-of-its-kind deep-space research initiative poised to transform space exploration and medical advancements on Earth.
The program was officially unveiled on Thursday, February 20, 2025, at The Explorers Club in New York City, and brought together top minds in space, science, and biotechnology.
About Twin Astra
Twin Astra is designed to unlock critical insights into human health through space-based research, driving breakthroughs that will impact both astronauts and Earth-based medicine. The program focuses on:
“By harnessing space as a biomedical testing ground, Twin Astra will redefine our understanding of human resilience in extreme environments,” said Professor Chris Mason, BioAstra Board Chair. “This research is crucial for protecting astronauts and unlocking medical discoveries that will benefit life on Earth and beyond.”
Launch Event: February 20, 2025
This exclusive gathering brought together astronauts, biotech leaders, philanthropists, investors, and innovators to explore the program’s groundbreaking potential.
“Twin Astra represents the next frontier of biomedical discovery,” said Savi Glowe, BioAstra CEO. “By pushing the limits of human biology in space, we are opening doors to new treatments, technologies, and insights that will redefine healthcare for generations to come.”
Event Highlights:
Event Details:
Date: Thursday, February 20
Time: 6:00 PM – 8:00 PM
Location: The Explorers Club, 46 East 70th Street, New York
Investor Inquiries: michal@bioastra.org
Website: www.bioastra.org; www.twinastra.org